A new study conducted at the Loyola University Health System in Maywood, Illinois indicates that breast cancer patients taking tamoxifen do not have an increased risk of developing uterine cancer. According to study author Dr. Ronald Potkul, study results on nearly 300 postmenopausal women indicates that for those "who did not have endometrial abnormalities when they began taking tamoxifen, there was a very low rate of developing pre-malignant conditions."
o read more about this study, click here
No comments:
Post a Comment